News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|July 25, 2022

A portable ultrasound device?

Author(s)Morgan Ebert

John Martin, MD, chief medical officer at Butterfly Network, discusses a recent study published in NEJM Evidence, which investigated Butterfly iQ vs a commercial ultrasound machine to detect gestational age.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FAQ: Breaking down ACOG's updated guidance for evaluating postmenopausal bleeding | Image credit: Stock.adobe.com

FAQ: Breaking down ACOG's updated guidance for evaluating postmenopausal bleeding

ByJoshua Fitch, Senior Editor

April 20th 2026

ACOG updates guidance for evaluating postmenopausal bleeding | Image Credit: © JHVEPhoto - © JHVEPhoto- stock.adobe.com.

ACOG updates guidance for evaluating postmenopausal bleeding

ByJoshua Fitch, Senior Editor

April 17th 2026

How does the FDA-cleared Delivery Date AI technology work? Raquel Dardik, MD, explains

How does the FDA-cleared Delivery Date AI technology work? Raquel Dardik, MD, explains

ByRaquel Dardik, MD

March 4th 2026

Raquel Dardik, MD, explains Ultrasound AI's FDA-cleared delivery date technology

Raquel Dardik, MD, explains Ultrasound AI's FDA-cleared delivery date technology

ByRaquel Dardik, MD

March 2nd 2026

Ultrasound AI receives De Novo clearance for predictive delivery date technology | Image credit: Contemporary OB/GYN

Ultrasound AI receives De Novo clearance for predictive delivery date technology

ByJoshua Fitch, Senior Editor

Published: March 2nd 2026 | Updated: March 2nd 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Endometriosis as a systemic disease, with Hugh Taylor, MD

FDA accepts extended duration sNDA for MIUDELLA IUD

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance

Amber Watters, MD, on emergency preparedness and building a version program